QUARTERLY FINANCIAL DATA (UNAUDITED) - Revised Consolidated Statements of Equity (Details)

v3.23.1

QUARTERLY FINANCIAL DATA (UNAUDITED) - Revised Consolidated Statements of Equity (Details) - USD ($)	3 Months Ended								6 Months Ended		9 Months Ended		12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance (in shares)							13,651,521
Beginning balance	$ 243,778,365	$ 262,833,595	$ 264,261,332	$ 263,631,523	$ 267,657,718	$ 250,882,083	$ 251,036,352	$ 149,399,827	$ 263,631,523	$ 149,399,827	$ 263,631,523	$ 149,399,827	$ 263,631,523	$ 149,399,827	$ 476,739,439
Net income (loss)	(552,849)	(15,501,704)	2,170,126	4,364,757	(188,675)	5,919,971	2,427,409	(10,694,263)	6,534,883	(8,266,854)	(8,966,821)	(2,346,883)	(9,519,669)	(2,535,558)	(306,067,579)
Non-controlling interest	116,893,428	116,863,817	116,816,116	116,816,116	116,816,116	116,816,116	116,611,762	115,323,036	116,816,116	116,611,762	116,863,817	116,816,116	116,893,428	116,816,116
Series A preferred stock dividends		(2,388,130)	(2,388,130)	(2,388,130)		(2,388,130)	(2,309,672)	(2,309,672)			(7,164,390)		(9,552,519)	(9,395,604)	(9,242,797)
Non-controlling interest income allocation	(809,212)	(809,212)	(809,212)	(809,212)	(809,212)	(1,046,304)	(1,010,951)	0	(1,618,424)	(1,010,951)	(2,427,636)	(2,057,255)	(3,236,848)	(2,866,467)	0
Common Stock dividends		(753,043)	(748,031)	(744,659)			(682,576)	(682,576)			(2,245,733)
Equity attributable to non-controlling interest						204,353	1,288,726	115,323,036						116,816,115
Common Stock dividends						(741,530)	(682,576)	$ (682,576)	(1,492,690)				(3,004,579)	(2,850,026)	(12,286,368)
Reinvestment of dividends paid to common stockholders		197,980	196,151	207,053		174,619	132,795		403,204		601,184		803,923	410,580
Common stock issued under director's compensation plan						22,500								22,500
Common Stock, accrued dividend equivalent		(34,145)									(34,145)		(67,431)
Crimson cash distribution on A-1 Units		(809,212)	(809,212)	(809,212)		(841,950)	(604,951)		(1,618,424)		(2,427,636)		(3,236,848)	(2,256,113)
Crimson Class A-2 Units dividends payment in kind						(204,353)	(406,000)			(406,000)		(610,353)	0	(610,353)	0
Stock-based compensation		233,024	151,359						151,359		384,383		612,117
Ending balance (in shares)								13,651,521
Ending balance	$ 239,666,517	$ 243,778,365	$ 262,833,595	$ 264,261,332	$ 263,631,523	267,657,718	$ 250,882,083	$ 251,036,352	262,833,595	$ 250,882,083	$ 243,778,365	267,657,718	239,666,517	263,631,523	149,399,827
Series A, Internalization
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Series A preferred stock dividends									$ (4,776,260)
Stock issued due to internalized transaction						4,245,112						4,245,112	0	4,245,112	0
Common Stock, Internalization
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stock issued due to internalized transaction						7,096,153						7,096,153	0	7,096,153	0
Class B Common Stock, Internalization
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stock issued due to internalized transaction						$ 3,288,890						$ 3,288,890	$ 0	$ 3,288,890	$ 0
Common Class B
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance (in shares)	683,761	683,761	683,761	683,761	683,761				683,761		683,761		683,761
Ending balance (in shares)	683,761	683,761	683,761	683,761	683,761	683,761			683,761		683,761	683,761	683,761	683,761
Series A Cumulative Redeemable Preferred Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	$ 129,525,675	$ 129,525,675	$ 129,525,675	$ 129,525,675					$ 129,525,675		$ 129,525,675		$ 129,525,675
Ending balance		$ 129,525,675	$ 129,525,675	$ 129,525,675	$ 129,525,675				$ 129,525,675		$ 129,525,675			$ 129,525,675
Common Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance (in shares)		15,060,857	14,960,628	14,893,184	14,866,799	13,673,326	13,651,521	13,651,521	14,893,184	13,651,521	14,893,184	13,651,521	14,893,184	13,651,521	13,638,916
Beginning balance		$ 15,060	$ 14,960	$ 14,893	$ 14,866	$ 13,673	$ 13,652	$ 13,652	$ 14,893	$ 13,652	$ 14,893	$ 13,652	$ 14,893	$ 13,652	$ 13,639
Reinvestment of dividends paid to common stockholders (in shares)			69,312	67,444		36,228	21,805		136,756				279,957	84,418
Reinvestment of dividends paid to common stockholders			$ 69	$ 67		$ 36	$ 21		$ 136				$ 280	$ 84
Common stock issued under director's compensation plan						$ 3								$ 3
Common stock issued under director's compensation plan (in shares)			30,917			3,399			30,917				80,817	3,399
Stock-based compensation			$ 31						$ 31				$ 81
Ending balance (in shares)	15,253,958		15,060,857	14,960,628	14,893,184	14,866,799	13,673,326	13,651,521	15,060,857	13,673,326		14,866,799	15,253,958	14,893,184	13,651,521
Ending balance	$ 15,254		$ 15,060	$ 14,960	$ 14,893	$ 14,866	$ 13,673	$ 13,652	$ 15,060	$ 13,673		$ 14,866	$ 15,254	$ 14,893	$ 13,652
Common Stock | Common Stock, Internalization
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stock issued due to internalized transaction						$ 1,154								$ 1,154
Stock issued, internalization transaction (in shares)						1,153,846								1,153,846
Common Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance (in shares)	15,176,911	15,060,857		14,893,184					14,893,184		14,893,184		14,893,184
Beginning balance	$ 15,177	$ 15,060		$ 14,893					$ 14,893		$ 14,893		$ 14,893
Reinvestment of dividends paid to common stockholders (in shares)		84,606									221,362
Reinvestment of dividends paid to common stockholders		$ 85									$ 221
Common stock issued under director's compensation plan (in shares)		31,448									62,365
Stock-based compensation		$ 32									$ 63
Ending balance (in shares)		15,176,911	15,060,857		14,893,184				15,060,857		15,176,911			14,893,184
Ending balance		$ 15,177	$ 15,060		$ 14,893				$ 15,060		$ 15,177			$ 14,893
Common Stock | Class B Common Stock, Internalization
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stock issued due to internalized transaction						$ 684								$ 684
Stock issued, internalization transaction (in shares)						683,761								683,761
Common Stock | Common Class B
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance (in shares)	683,761	683,761	683,761	683,761	683,761	0	0	0	683,761	0	683,761	0	683,761	0	0
Beginning balance	$ 684	$ 684	$ 684	$ 684	$ 684	$ 0	$ 0	$ 0	$ 684	$ 0	$ 684	$ 0	$ 684	$ 0	$ 0
Ending balance (in shares)	683,761	683,761	683,761	683,761	683,761	683,761	0	0	683,761	0	683,761	683,761	683,761	683,761	0
Ending balance	$ 684	$ 684	$ 684	$ 684	$ 684	$ 684	$ 0	$ 0	$ 684	$ 0	$ 684	$ 684	$ 684	$ 684	$ 0
Preferred Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	129,525,675	129,525,675		129,525,675	129,525,675	125,270,350	125,270,350	125,270,350	129,525,675	125,270,350	129,525,675	125,270,350	129,525,675	125,270,350	125,493,175
Ending balance	129,525,675	129,525,675	129,525,675		129,525,675	129,525,675	125,270,350	125,270,350	129,525,675	125,270,350	129,525,675	129,525,675	129,525,675	129,525,675	125,270,350
Preferred Stock | Series A, Internalization
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stock issued due to internalized transaction						4,255,325								4,255,325
Additional Paid-in Capital
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	329,796,049	332,588,181	335,376,932	338,302,735	341,331,070	333,890,657	336,750,132	339,742,380	338,302,735	339,742,380	338,302,735	339,742,380	338,302,735	339,742,380	360,844,497
Series A preferred stock dividends		(2,388,130)	(2,388,130)	(2,388,130)		(2,388,130)	(2,309,672)	(2,309,672)			(7,164,390)		(9,552,519)	(9,395,604)	(9,242,797)
Common Stock dividends		(753,043)	(748,031)	(744,659)			(682,576)	(682,576)			(2,245,733)
Common Stock dividends						(741,530)	(682,576)	(682,576)	(1,492,690)				(3,004,579)	(2,850,026)	(12,286,368)
Reinvestment of dividends paid to common stockholders		197,895	196,082	206,986		174,583	132,774		403,068		600,963		803,643	410,496
Common stock issued under director's compensation plan						22,497								22,497
Common Stock, accrued dividend equivalent		(34,145)									(34,145)		(67,431)
Stock-based compensation		185,291	151,328						151,328		336,619		534,724
Ending balance	327,016,573	329,796,049	332,588,181	335,376,932	338,302,735	341,331,070	333,890,657	336,750,132	332,588,181	333,890,657	329,796,049	341,331,070	327,016,573	338,302,735	339,742,380
Additional Paid-in Capital | Series A, Internalization
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Series A preferred stock dividends									(4,776,260)
Stock issued due to internalized transaction						(10,213)								(10,213)
Additional Paid-in Capital | Common Stock, Internalization
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stock issued due to internalized transaction						7,094,999								7,094,999
Additional Paid-in Capital | Class B Common Stock, Internalization
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stock issued due to internalized transaction						3,288,206								3,288,206
Retained Deficit
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	(332,423,037)	(316,112,121)	(317,473,035)	(321,028,580)	(320,030,693)	(324,904,359)	(326,320,818)	(315,626,555)	(321,028,580)	(315,626,555)	(321,028,580)	(315,626,555)	(321,028,580)	(315,626,555)	(9,611,872)
Net income (loss)		(16,310,916)	1,360,914	3,555,545		4,873,667	1,416,458	(10,694,263)	4,916,459		(11,394,457)		(12,756,517)	(5,402,025)	(306,067,579)
Ending balance	(333,785,097)	(332,423,037)	(316,112,121)	(317,473,035)	(321,028,580)	(320,030,693)	(324,904,359)	(326,320,818)	(316,112,121)	(324,904,359)	(332,423,037)	(320,030,693)	(333,785,097)	(321,028,580)	(315,626,555)
Non-Controlling Interest
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	116,863,817	116,816,116	116,816,116	116,816,116	116,816,116	116,611,762	115,323,036	0	116,816,116	0	116,816,116	0	116,816,116	0	0
Net income (loss)		809,212	809,212	809,212		1,046,304	1,010,951		1,618,424		2,427,636		3,236,848	2,866,467
Equity attributable to non-controlling interest						204,353	1,288,726	115,323,036						116,816,115
Crimson cash distribution on A-1 Units		(809,212)	(809,212)	(809,212)		(841,950)	(604,951)		(1,618,424)		(2,427,636)		(3,236,848)	(2,256,113)
Crimson Class A-2 Units dividends payment in kind						(204,353)	(406,000)							(610,353)
Stock-based compensation		47,701									47,701		77,312
Ending balance	116,893,428	116,863,817	116,816,116	116,816,116	116,816,116	116,816,116	116,611,762	115,323,036	116,816,116	116,611,762	116,863,817	116,816,116	116,893,428	116,816,116	0
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	243,778,365	262,833,595	264,261,332	263,631,523	267,657,718	250,882,083	251,036,352	149,399,827	263,631,523	149,399,827	263,631,523	149,399,827	263,631,523	149,399,827
Net income (loss)		(15,501,704)	2,170,126	4,364,757		5,919,971	2,427,409	(10,694,263)	6,534,883	(8,266,854)	(8,966,821)	(2,346,883)		(2,535,558)
Non-controlling interest		124,193,250	124,353,713	124,196,254	122,945,172	121,534,724	119,220,989	116,928,344	124,353,713	119,220,989	124,193,250	121,534,724		122,945,172
Series A preferred stock dividends		(2,388,130)	(2,388,130)	(2,388,130)		(2,388,130)	(2,309,672)	(2,309,672)			(7,164,390)			(9,395,604)
Non-controlling interest income allocation		(601,048)	(966,671)	(2,060,294)		(3,155,685)	(2,014,870)	(1,605,308)	(3,026,965)	(3,620,178)	(3,628,013)	(6,775,863)		(8,995,523)
Common Stock dividends		(753,043)	(748,031)	(744,659)			(682,576)	(682,576)			(2,245,733)
Equity attributable to non-controlling interest						204,353	1,288,726	115,323,036						116,816,115
Common Stock dividends						(741,530)	(682,576)	(682,576)	(1,492,690)					(2,850,026)
Reinvestment of dividends paid to common stockholders		197,980	196,151	207,053		174,619	132,795		403,204		601,184			410,580
Common stock issued under director's compensation plan						22,500								22,500
Common Stock, accrued dividend equivalent		(34,145)									(34,145)
Crimson cash distribution on A-1 Units		(809,212)	(809,212)	(809,212)		(841,950)	(604,951)		(1,618,424)		(2,427,636)			(2,256,113)
Crimson Class A-2 Units dividends payment in kind						(204,353)	(406,000)			(406,000)		(610,353)		(610,353)
Stock-based compensation		233,024	151,359						151,359		384,383
Ending balance		243,778,365	262,833,595	264,261,332	263,631,523	267,657,718	$ 250,882,083	$ 251,036,352	262,833,595	$ 250,882,083	243,778,365	267,657,718		263,631,523	$ 149,399,827
As Previously Reported | Series A, Internalization
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Series A preferred stock dividends									(4,776,260)
Stock issued due to internalized transaction						4,245,112						4,245,112		4,245,112
As Previously Reported | Common Stock, Internalization
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stock issued due to internalized transaction						7,096,153						7,096,153		7,096,153
As Previously Reported | Class B Common Stock, Internalization
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stock issued due to internalized transaction						$ 3,288,890						$ 3,288,890		3,288,890
As Previously Reported | Series A Cumulative Redeemable Preferred Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	$ 129,525,675	129,525,675	129,525,675	129,525,675					129,525,675		129,525,675		$ 129,525,675
Ending balance		$ 129,525,675	$ 129,525,675	$ 129,525,675	$ 129,525,675				$ 129,525,675		$ 129,525,675			$ 129,525,675
As Previously Reported | Common Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance (in shares)		15,060,857	14,960,628	14,893,184	14,866,799	13,673,326	13,651,521	13,651,521	14,893,184	13,651,521	14,893,184	13,651,521	14,893,184	13,651,521
Beginning balance		$ 15,060	$ 14,960	$ 14,893	$ 14,866	$ 13,673	$ 13,652	$ 13,652	$ 14,893	$ 13,652	$ 14,893	$ 13,652	$ 14,893	$ 13,652
Reinvestment of dividends paid to common stockholders (in shares)			69,312	67,444		36,228	21,805		136,756					84,418
Reinvestment of dividends paid to common stockholders			$ 69	$ 67		$ 36	$ 21		$ 136					$ 84
Common stock issued under director's compensation plan						$ 3								$ 3
Common stock issued under director's compensation plan (in shares)			30,917			3,399			30,917					3,399
Stock-based compensation			$ 31						$ 31
Ending balance (in shares)			15,060,857	14,960,628	14,893,184	14,866,799	13,673,326	13,651,521	15,060,857	13,673,326		14,866,799		14,893,184	13,651,521
Ending balance			$ 15,060	$ 14,960	$ 14,893	$ 14,866	$ 13,673	$ 13,652	$ 15,060	$ 13,673		$ 14,866		$ 14,893	$ 13,652
As Previously Reported | Common Stock | Common Stock, Internalization
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stock issued due to internalized transaction						$ 1,154								$ 1,154
Stock issued, internalization transaction (in shares)						1,153,846								1,153,846
As Previously Reported | Common Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance (in shares)	15,176,911	15,060,857		14,893,184					14,893,184		14,893,184		14,893,184
Beginning balance	$ 15,177	$ 15,060		$ 14,893					$ 14,893		$ 14,893		$ 14,893
Reinvestment of dividends paid to common stockholders (in shares)		84,606									221,362
Reinvestment of dividends paid to common stockholders		$ 85									$ 221
Common stock issued under director's compensation plan (in shares)		31,448									62,365
Stock-based compensation		$ 32									$ 63
Ending balance (in shares)		15,176,911	15,060,857		14,893,184				15,060,857		15,176,911			14,893,184
Ending balance		$ 15,177	$ 15,060		$ 14,893				$ 15,060		$ 15,177			$ 14,893
As Previously Reported | Common Stock | Class B Common Stock, Internalization
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stock issued due to internalized transaction						$ 684								$ 684
Stock issued, internalization transaction (in shares)						683,761								683,761
As Previously Reported | Common Stock | Common Class B
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance (in shares)	683,761	683,761	683,761	683,761	683,761	0	0	0	683,761	0	683,761	0	683,761	0
Beginning balance	$ 684	$ 684	$ 684	$ 684	$ 684	$ 0	$ 0	$ 0	$ 684	$ 0	$ 684	$ 0	$ 684	$ 0
Ending balance (in shares)		683,761	683,761	683,761	683,761	683,761	0	0	683,761	0	683,761	683,761		683,761	0
Ending balance		$ 684	$ 684	$ 684	$ 684	$ 684	$ 0	$ 0	$ 684	$ 0	$ 684	$ 684		$ 684	$ 0
As Previously Reported | Preferred Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	129,525,675	129,525,675		129,525,675	129,525,675	125,270,350	125,270,350	125,270,350	129,525,675	125,270,350	129,525,675	125,270,350	129,525,675	125,270,350
Ending balance		129,525,675	129,525,675		129,525,675	129,525,675	125,270,350	125,270,350	129,525,675	125,270,350	129,525,675	129,525,675		129,525,675	125,270,350
As Previously Reported | Preferred Stock | Series A, Internalization
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stock issued due to internalized transaction						4,255,325								4,255,325
As Previously Reported | Additional Paid-in Capital
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	329,796,049	332,588,181	335,376,932	338,302,735	341,331,070	333,890,657	336,750,132	339,742,380	338,302,735	339,742,380	338,302,735	339,742,380	338,302,735	339,742,380
Series A preferred stock dividends		(2,388,130)	(2,388,130)	(2,388,130)		(2,388,130)	(2,309,672)	(2,309,672)			(7,164,390)			(9,395,604)
Common Stock dividends		(753,043)	(748,031)	(744,659)			(682,576)	(682,576)			(2,245,733)
Common Stock dividends						(741,530)	(682,576)	(682,576)	(1,492,690)					(2,850,026)
Reinvestment of dividends paid to common stockholders		197,895	196,082	206,986		174,583	132,774		403,068		600,963			410,496
Common stock issued under director's compensation plan						22,497								22,497
Common Stock, accrued dividend equivalent		(34,145)									(34,145)
Stock-based compensation		185,291	151,328						151,328		336,619
Ending balance		329,796,049	332,588,181	335,376,932	338,302,735	341,331,070	333,890,657	336,750,132	332,588,181	333,890,657	329,796,049	341,331,070		338,302,735	339,742,380
As Previously Reported | Additional Paid-in Capital | Series A, Internalization
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Series A preferred stock dividends									(4,776,260)
Stock issued due to internalized transaction						(10,213)								(10,213)
As Previously Reported | Additional Paid-in Capital | Common Stock, Internalization
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stock issued due to internalized transaction						7,094,999								7,094,999
As Previously Reported | Additional Paid-in Capital | Class B Common Stock, Internalization
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stock issued due to internalized transaction						3,288,206								3,288,206
As Previously Reported | Retained Deficit
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	(339,752,470)	(323,649,718)	(324,853,173)	(327,157,636)	(324,749,302)	(327,513,587)	(327,926,126)	(315,626,555)	(327,157,636)	(315,626,555)	(327,157,636)	(315,626,555)	(327,157,636)	(315,626,555)
Net income (loss)		(16,102,752)	1,203,455	2,304,463		2,764,286	412,539	(12,299,571)	3,507,918		(12,594,834)			(11,531,081)
Ending balance		(339,752,470)	(323,649,718)	(324,853,173)	(327,157,636)	(324,749,302)	(327,513,587)	(327,926,126)	(323,649,718)	(327,513,587)	(339,752,470)	(324,749,302)		(327,157,636)	(315,626,555)
As Previously Reported | Non-Controlling Interest
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	124,193,250	124,353,713	124,196,254	122,945,172	121,534,724	119,220,989	116,928,344	0	122,945,172	0	122,945,172	0	122,945,172	0
Net income (loss)		601,048	966,671	2,060,294		3,155,685	2,014,870	1,605,308	3,026,965		3,628,013			8,995,523
Equity attributable to non-controlling interest						204,353	1,288,726	115,323,036						116,816,115
Crimson cash distribution on A-1 Units		(809,212)	(809,212)	(809,212)		(841,950)	(604,951)		(1,618,424)		(2,427,636)			(2,256,113)
Crimson Class A-2 Units dividends payment in kind						(204,353)	(406,000)							(610,353)
Stock-based compensation		47,701									47,701
Ending balance		124,193,250	124,353,713	124,196,254	122,945,172	121,534,724	119,220,989	116,928,344	124,353,713	119,220,989	124,193,250	121,534,724		122,945,172	$ 0
Effect of Restatement
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	0	0	0	0	0	0	0		0		0		0
Net income (loss)		0	0	0		0	0	0	0	0	0	0		0
Non-controlling interest		(7,329,433)	(7,537,597)	(7,380,138)	(6,129,056)	(4,718,608)	(2,609,227)	(1,605,308)	(7,537,597)	(2,609,227)	(7,329,433)	(4,718,608)		(6,129,056)
Series A preferred stock dividends								0
Non-controlling interest income allocation		(208,164)	157,459	1,251,082		2,109,381	1,003,919	1,605,308	1,408,541	2,609,227	1,200,377	4,718,608		6,129,056
Common Stock dividends								0
Equity attributable to non-controlling interest								0
Crimson Class A-2 Units dividends payment in kind										0		0		0
Ending balance	0	0	0	0	$ 0	$ 0	$ 0	$ 0	0	$ 0	0	0	0	0
Adjustments to 2021 Net Income (loss)		0		0							0
Adjustments to Q1 - Q2 2022 Net Income (loss)		0
Effect of Restatement | Series A, Internalization
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stock issued due to internalized transaction												0		0
Effect of Restatement | Common Stock, Internalization
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stock issued due to internalized transaction												0		0
Effect of Restatement | Class B Common Stock, Internalization
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stock issued due to internalized transaction												$ 0		$ 0
Effect of Restatement | Series A Cumulative Redeemable Preferred Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	0	0	0
Ending balance	$ 0	$ 0	$ 0	$ 0					$ 0		$ 0		$ 0
Effect of Restatement | Common Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance (in shares)		0	0	0	0	0	0		0		0		0
Beginning balance		$ 0	$ 0	$ 0	$ 0	$ 0	$ 0		$ 0		$ 0		$ 0
Ending balance (in shares)	0		0	0	0	0	0	0	0	0		0	0	0
Ending balance	$ 0		$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0		$ 0	$ 0	$ 0
Effect of Restatement | Common Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance (in shares)	0
Beginning balance	$ 0
Ending balance (in shares)		0									0
Ending balance		$ 0									$ 0
Effect of Restatement | Common Stock | Common Class B
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance (in shares)	0	0	0	0	0	0	0		0		0		0
Beginning balance	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0		$ 0		$ 0		$ 0
Ending balance (in shares)	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Ending balance	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0
Effect of Restatement | Preferred Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	0			0	0	0	0		0		0		0
Ending balance		0			0	0	0	0		0	0	0		0
Effect of Restatement | Additional Paid-in Capital
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	0	0	0	0	0	0	0		0		0		0
Ending balance	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effect of Restatement | Retained Deficit
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	7,329,433	7,537,597	7,380,138	6,129,056	4,718,608	2,609,227	1,605,308		6,129,056		6,129,056		6,129,056
Net income (loss)		(208,164)	157,459	1,251,082		2,109,381	1,003,919	1,605,308	1,408,541		1,200,377			6,129,056
Ending balance	7,380,138	7,329,433	7,537,597	7,380,138	6,129,056	4,718,608	2,609,227	1,605,308	7,537,597	2,609,227	7,329,433	4,718,608	7,380,138	6,129,056
Adjustments to 2021 Net Income (loss)		6,129,056		6,129,056					6,129,056		6,129,056
Adjustments to Q1 - Q2 2022 Net Income (loss)		(1,408,541)
Effect of Restatement | Non-Controlling Interest
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	(7,329,433)	(7,537,597)	(7,380,138)	(6,129,056)	(4,718,608)	(2,609,227)	(1,605,308)		(6,129,056)		(6,129,056)		(6,129,056)
Net income (loss)		208,164	(157,459)	(1,251,082)		(2,109,381)	(1,003,919)	(1,605,308)	(1,408,541)		(1,200,377)			(6,129,056)
Ending balance	$ (7,380,138)	(7,329,433)	$ (7,537,597)	(7,380,138)	$ (6,129,056)	$ (4,718,608)	$ (2,609,227)	$ (1,605,308)	(7,537,597)	$ (2,609,227)	(7,329,433)	$ (4,718,608)	$ (7,380,138)	$ (6,129,056)
Adjustments to 2021 Net Income (loss)		(6,129,056)		$ (6,129,056)					$ (6,129,056)		$ (6,129,056)
Adjustments to Q1 - Q2 2022 Net Income (loss)		$ 1,408,541